Steroid Dosing for URI in Patients with Type 2 Diabetes

Steroid Selection and Dosing

For short-term management of URI symptoms in patients with type 2 diabetes, prednisolone is preferred over dexamethasone due to its shorter half-life and less pronounced hyperglycemic effects 1, 2
The American Diabetes Association recommends initial dosing of prednisolone at 0.5 mg/kg/day for 5 days, which translates to approximately 30-40 mg daily for most adults, with morning administration preferred to minimize sleep disturbances and better mimic natural cortisol rhythm 3

Anticipate hyperglycemia primarily between midday and midnight, with glucose levels often normalizing overnight, according to the American Association of Clinical Endocrinologists 4, 5
For patients on oral diabetes medications, the American Diabetes Association recommends continuing baseline diabetes medications and monitoring blood glucose 4 times daily during steroid therapy, with consideration of temporary insulin if blood glucose consistently exceeds high levels 3, 6
For patients already on insulin therapy, the European Association for the Study of Diabetes recommends increasing total daily insulin dose by approximately 30-50% during steroid treatment, with NPH insulin being particularly effective for managing steroid-induced hyperglycemia due to its peak action profile 1, 2, 3

Higher steroid doses and longer duration of therapy increase hyperglycemia risk, according to the American Diabetes Association 4
Patients with pre-existing glucose intolerance or risk factors for diabetes require closer monitoring, as recommended by the American Association of Clinical Endocrinologists 3

Check blood glucose levels at least daily while on steroid therapy, preferably 2-4 hours after steroid administration when hyperglycemic effect is maximal, as recommended by the American Diabetes Association 2, 3
For high-risk patients, monitor glucose more frequently (2-4 times daily), according to the Journal for ImmunoTherapy of Cancer 6

If the patient requires hospitalization, more intensive insulin regimens may be needed, with basal-bolus insulin at 0.5 units/kg/day, as recommended by the European Association for the Study of Diabetes 2
Insulin requirements typically decrease rapidly after steroid discontinuation, requiring prompt dose adjustments to avoid hypoglycemia, according to the American Association of Clinical Endocrinologists 2
Sulfonylureas are not recommended for managing steroid-induced hyperglycemia due to risk of prolonged hypoglycemia, as stated by the European Association for the Study of Diabetes 2